News

Tim Freeman, director of operations for Freeman Technology, will again join academics and other industry experts for the next Mixing Consultants course covering aspects of powder characterization. The

Transgene Bioteck (TBL) has signed a licensing and technology transfer agreement with Dr. Reddy’s Laboratories (DRL), Hyderabad, for the out licensing of a technology to be used for

PLX4032 is an oral and targeted drug that is designed to inhibit the BRAF cancer-causing mutation that occurs in about 50% of melanomas and about 8% of all

The European Commission has notified Lundbeck that it has opened proceedings against the company. The purpose is to identify whether Lundbeck has misused a dominant position or has

3SBio, a company focused on research, development, manufacturing and marketing of biopharmaceutical products primarily in China, has submitted its application for a registrational clinical trial to the Chinese

The company said that Talitha Best and Eva Kemps of Flinders University in Adelaide and Janet Bryan of the University of South Australia in Adelaide, have published their

Watson Pharmaceuticals has confirmed that its subsidiary, Watson Laboratories, has filed an Abbreviated New Drug Application (ANDA) with the FDA seeking approval to market its levonorgestrel and ethinyl

The Royal Victoria Hospital (RVH) in Barrie, Ontario, has become the first Canadian hospital to order a RIVA System (Robotic IV Automation System) – a self-contained unit for

Pfizer and Debiopharm have entered into a co-development agreement to conduct a phase 3 trial of Tremelimumab (CP675,206), a fully human anti-CTLA4 monoclonal antibody, for the treatment of